Assessing the Clinical Utility of Point of Care HbA1c in the Ophthalmology Outpatient Setting

Point-of-care HbA1c Measurements in Oral Cancer and Control Patients in Hungary

“…Therefore, a more detailed investigation of this very specific patient population (oral cancer group), probably with CGM settings, is required. POC HbA1c represents a cost-effective, reproducible, and clinically significant tool for the management of DM in an outpatient setting, allowing the rapid recognition of high-risk patients and appropriate referral to secondary DM services (41)(42)(43).…”